Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹18.65
Market cap
₹44.22 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.8×Sector 47.4×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4Board Meeting Date 4Annual General Meeting 4Financial Results 3Board Meeting Outcome 3Management Change 2Capacity Expansion 2Results Update 1Legal & Regulatory 1Capital Structure Change 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

3 announcements with these filters

19:02 IST BSE
Financial Results

Kabra Drugs Financial Results

Kabra Drugs reported a total income of ₹93.23 Crore and a net profit of ₹4.96 Crore for FY2026. The Board approved these audited results today.

Value
₹93.23 Cr
Read the filing ↗